Quality-of-Life Assessment
OtherQLQ-C30 SAT32
Other names: QoL
NCT Number: NCT00045019
RATIONALE: Questionnaires may help determine cancer patients' satisfaction with the quality of care they received in the hospital.
PURPOSE: Clinical trial to determine the effectiveness of questionnaires in assessing cancer patients' satisfaction with the quality of care they received in the hospital.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Institut Jules Bordet, Brussels, Belgium
OBJECTIVES:
OUTLINE: This is a descriptive, multicenter study. Patients are stratified according to age (18 to 49 vs 50 and over) and the cancer therapy received in hospital (surgery vs chemotherapy).
Patients in all strata receive the QLQ-SAT32 and QLQ-C30 questionnaires, a debriefing questionnaire, and the Oberst patient satisfaction visual analog scale prior to hospital discharge. Patients complete the materials at home within 7 days of discharge. A group of 100 patients have a repeat QLQ-SAT32 module mailed to them to be completed within 7 days of receipt of first questionnaire.
PROJECTED ACCRUAL: A total of 640-768 patients (160-192 per stratum) will be accrued for this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
Age
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Other
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
QLQ-C30 SAT32
Other names: QoL
European Organisation for Research and Treatment of Cancer - EORTC
Network
An International Field-Testing Study Of The Reliability And Validity Of A Patient Satisfaction Module (QLQ-SAT32) Assessing Cancer Patients' Perception Of The Quality Of Care Received Within The Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02088775
Adenocarcinoma, Adult Primary Hepatocellular Carcinoma
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01705548
Brain Diseases, Brain Neoplasms
Atlanta, Georgia, United States
View Trial DetailsNCT00343460
Nausea, Nausea and Vomiting
Anniston, Alabama, United States
View Trial DetailsNCT00712712
Metastatic Cancer, Neoplasm Metastasis
Bordeaux, France
View Trial Details